Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 681-689

  Pankow, James S ^a   Folsom, Aaron R ^b   Cushman, Mary ^c   Borecki, Ingrid B ^d   Hopkins, Paul N ^e   Eckfeldt, John H ^f   Tracy, Russell P ^g  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^g UNIVERSITY OF VERMONT   (United States)

Author keywords

Albumin; C reactive protein; Inflammation; Interleukin 1; White blood cell count

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 1;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CHROMOSOME 2Q; CONGESTIVE CARDIOMYOPATHY; DEMOGRAPHY; DISEASE MARKER; FAMILY HISTORY; FEMALE; GENE CLUSTER; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SOCIAL ASPECT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHROMOSOMES, HUMAN, PAIR 2; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LINKAGE (GENETICS); MICROSATELLITE REPEATS; MIDDLE AGED; SERUM ALBUMIN;

EID: 0035864605     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00586-4     Document Type: Article

References (56)

1. Atherosclerosis - An inflammatory disease
2. Serum albumin, coronary heart disease, and death
3. White blood cell count, coronary heart disease, and death: The NHANES I epidemiologic follow-up study
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina
5. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
6. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
7. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
8. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
9. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992
10. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: Cohort study
11. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial
12. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
13. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
14. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice
15. Interleukin-6 exacerbates early atherosclerosis in mice
16. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
17. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
18. Acute-phase inflammatory response to local periodontal disease and systemic conditions in the US population
19. Risk factors for coronary heart disease and acute-phase proteins. A population-based study
20. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
21. Elevated C-reactive protein levels in overweight and obese adults
22. Hormone replacement therapy, inflammation, and hemostasis in elderly women
23. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
24. The interleukin-1 genotype as a severity factor in adult periodontal disease
25. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
26. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
27. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI Family Heart Study
28. NHLBI Family Heart Study: Objectives and design
29. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
30. Dinucleotide repeat polymorphism in the human interleukin 1, alpha gene (IL1A)
31. General purpose model and a computer program for combined segregation and path analysis (SEGPATH): Automatically creating computer programs from symbolic language model specifications
32. A multivariate and multilocus variance components approach using structural relationships to assess quantitative trait linkage via SEGPATH
33. Complete multipoint sib-pair analysis of qualitative and quantitative traits
34. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice
35. Biological variation of acute phase proteins
36. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris
37. Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: Assessment and implications for epidemiology
38. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects
39. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences
40. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
41. Heritability of clinical chemistries in an older twin cohort: The NHLBI Twin Study
42. Genetic and environmental determinants of 17 serum biochemical traits in Brazilian twins
43. The effects of inheritance on constituents of plasma: A twin study on some biochemical variables
44. Intrapair differences of the blood cell components and lymphocyte subsets in monozygotic and dizygotic twins
45. Evidence for multiple determinants of the body mass index: The National Heart, Lung, and Blood Institute Family Heart Study
46. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
47. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
48. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
49. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo
50. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
51. Inflammation in cardiovascular disease: Cart, horse, or both?
52. Inflammation markers and coronary heart disease
53. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes
54. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
55. Multipoint quantitative-trait linkage analysis in general pedigrees
56. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?